Instantly Value Your Royalty Asset

Get a free, data-driven valuation in seconds. No strings attached.

Start My Free Valuation
Secure & Confidential
Instant Results
100% Free

How It Works

Get your personalized royalty valuation in three simple steps. Our process is transparent, fast, and based on proven financial methodology.

Step 1

Provide Asset Details

Enter basic information about your drug or therapy asset, including indication, stage of development, and royalty percentage.

Step 2

AI-Powered Analysis

Our proprietary model analyzes public data sources, market trends, and therapy archetypes to create a comprehensive forecast.

Step 3

Receive Instant Valuation

Get your detailed valuation report in seconds, complete with revenue projections and key assumptions you can review.

Built on Trusted Data & Proven Methodology

Our valuation model combines institutional-grade financial analysis with transparent assumptions you can review and understand.

Public Data Sources

Our model leverages trusted public sources including FDA Orange Book, clinical trial databases, and peer-reviewed epidemiological studies.

Deterministic Logic

No black boxes here. Our valuation uses transparent, industry-standard DCF methodology that any financial professional can validate.

Therapy Archetypes

We handle diverse therapy types—from chronic treatments to acute interventions, each with appropriate duration and adoption models.

Conservative Assumptions

Our model uses prudent, defensible assumptions. We show you exactly what discount rates, market shares, and timelines we're using.

Continuously Updated

Market conditions change. Our model incorporates the latest regulatory approvals, competitive landscapes, and pricing benchmarks.

Expert-Validated

Developed with input from CFA-chartered analysts with deep experience in biopharma valuation and royalty transactions.

Your Data is Safe & Confidential

We understand the sensitivity of your royalty information and protect it accordingly.

Bank-Level Encryption

All data transmission uses 256-bit SSL encryption, the same security standard used by major financial institutions.

No Account Required

Get your valuation without creating an account. We only collect the minimum information needed to provide your report.

Data Minimization

We don't store sensitive details about your asset. Your valuation inputs are processed and then securely purged.

GDPR Compliant

We follow strict data protection regulations, giving you full control over your personal information.

No Third-Party Sharing

Your information is never sold or shared with third parties without your explicit consent.

SSL Encrypted
GDPR Compliant
SOC 2 Certified

RoyaltyIQ

Instant pharmaceutical royalty valuations powered by data and AI

© 2025 RoyaltyIQ. All rights reserved.